QueF nitrile reductases: Catalytic mechanism and advances in biocatalyst development
Protein Science · 2026-12 · 35 (12)
DOI: 10.1002/pro.70838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Protein Science, online erschienen am 05.11.2026. Verfasst von Chenlu Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University College London, London, UK. Hauptthemen laut MEDLINE: Oxidoreductases, Nitriles. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: UKRI-EPSRC.
Abstract (Originalsprache)
Nitrile‐to‐amine reduction is a key transformation in organic and industrial synthesis, providing access to pharmaceutical, agrochemical, and materials manufacturing relevant primary amines. QueF nitrile reductases represent a unique class of biocatalysts capable of catalyzing the NAD(P)H‐dependent four‐electron reduction of nitriles under mild conditions. Despite their biocatalytic potential, the practical application of QueF enzymes is severely constrained by an exceptionally narrow substrate scope. This review presents a comprehensive analysis of QueF research, from its discovery, structural and mechanistic elucidation to the most recent protein‐engineering efforts. Experimental evidence indicates that the long evolutionary optimization of the active site, characterized by a highly specialized substrate‐binding pocket, is the primary determinant of QueF's substrate specificity. A critical analysis of the relationships between key active‐site residues and substrate functional groups, integrating structural, mutagenesis, and computational insights, rationalizes selectivity trends. Ultimately, this work outlines the fundamental challenges associated with expanding QueF substrate tolerance and identifies plausible strategies for future engineering. Continued progress will rely on a deeper understanding of catalytic mechanism, active‐site dynamics, and coordinated multi‐residue redesign, positioning QueF as a valuable model system for the development of next‐generation nitrile‐reducing biocatalysts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University College London, London, UK.
- Manufacturing Futures Lab, University College London, London, UK.
- Oncology R&D, AstraZeneca, Cambridge, UK.
ORCID-Profile: Chenlu Li, Roland Kulanda, Daniele Castagnolo, Michele Crotti
Förderung
- UKRI-EPSRC
Zitieren
APA
Li, C., Kulanda, R., Staniland, S., Castagnolo, D., & Crotti, M. (2026). QueF nitrile reductases: Catalytic mechanism and advances in biocatalyst development. Protein Science, 35(12). https://doi.org/10.1002/pro.70838
Vancouver
Li C, Kulanda R, Staniland S, Castagnolo D, Crotti M. QueF nitrile reductases: Catalytic mechanism and advances in biocatalyst development. Protein Science. 2026;35(12). doi:10.1002/pro.70838
BibTeX
@article{Li2026,
author = {Li, Chenlu and Kulanda, Roland and Staniland, Sam and Castagnolo, Daniele and Crotti, Michele},
title = {QueF nitrile reductases: Catalytic mechanism and advances in biocatalyst development},
journal = {Protein Science},
year = {2026},
volume = {35},
number = {12},
doi = {10.1002/pro.70838}
}
EUVIMED